Skip to content
healthcare.dev
Get a free key

Azacitidine

NDC 68001-313, Azacitidine, injection, powder, lyophilized, for solution, from BluePoint Laboratories.

Product NDC
68001-313
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208216
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
68001-313-56680010313561 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68001-313-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68001-313

Use it

Look up 68001-313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.